Skip to main content


This information should not be used for self-diagnosis or in place of a qualified physician's care.

Reviewed Dec 2020

The basics
  • Guidelines for treating this cancer have been developed by the Genitourinary (GU) Tumour Group.
  • For health professional information on treating this cancer, please see our Cancer Management Guidelines.
  • Other names/types of kidney cancers: renal cell cancer, renal cell carcinoma, renal cell adenocarcinoma, transitional cell carcinoma, hypernephroma, chromophobe and papillary renal cell carcinoma, and Wilms' Tumour.
  • The kidneys are two bean-shaped organs 4.5 inches long (11.4 cm) situated against the back abdominal wall, one on each side of the spine.
  • The kidneys filter the body's blood to remove salt, toxins and water. The end result of the filtering is the creation of urine (pee).
  • The kidneys also return water to the body to maintain the balance of water that body tissues need.
  • Hormones produced by the pituitary gland control the function of the kidneys in balancing the body's water content.
  • Having only one kidney does not create a medical problem. If one kidney is removed, the remaining kidney grows larger over the next few months to handle the extra load.
  • 90% of tumours arise in the parenchyma and are commonly called renal cell cancers.
  • The survival rate for patients with early stage kidney cancer is up to 75%.

What causes it and who gets it?

Listed below are some of the known risk factors for this cancer. Not all of the risk factors below may cause this cancer, but they may be contributing factors.
  • Kidney cancer accounts for about 4% of all cancers.
  • This cancer affects more men than women (2 or 3 times as many men as women) [see note, Statistics].
  • Black people have a slightly higher risk of kidney cancer.
  • If your sibling has had kidney cancer, you may be more likely to get it.
  • This cancer occurs mostly in people between the ages of 30 – 70, but especially in men aged 40-75 [see note, Statistics].
  • Exposure to tobacco smoke is a known risk factor. The risk is about double (2x) in cigarette smokers versus non-smokers.
  • The use of drugs containing phenacetin is a risk factor. The use of phenacetin in prescription or over-the-counter drugs was discontinued in Canada in 1973, so this risk factor is diminishing in the general population. However, the illegal drug cocaine is often 'cut' with phenacetin.
  • Long-term use of diuretic drugs may increase risk.
  • Long-term dialysis may increase risk.
  • Long-term use of pain medications, including over-the-counter medications, may increase risk.
  • Exposure to cadmium – batteries, paint, welding materials contain cadmium – may increase risk. This is especially true for smokers who are exposed to cadmium.
  • A specific gene mutation known as Von Hippel-Lindau may be responsible over 40% of clear cell kidney cancers.
  • Coke oven workers appear to have an above average rate of kidney cancer (coke ovens are used mainly in the aluminum, steel, graphite, electrical, and construction industries).
  • Statistics
    NOTE:  Available statistics do not have information about the inclusion of transgender and gender diverse participants. It is unknown how these statistics apply to transgender and gender diverse people.  Patients are advised to speak with their primary care provider or specialists about their individual considerations and recommendations.

Can I help to prevent it?

  • To reduce your risk, don’t smoke, and avoid exposure to tobacco and cigarette smoke. Even if you have been using tobacco for many years, quitting will reduce your cancer risk. Support is available to help you successfully quit. Visit the BC Cancer Agency’s Prevention page on Tobacco for information and resources. 
  • Being overweight is a risk factor for kidney cancer. Together, healthy eating and regular physical activity are the best way to maintain a healthy body weight. 
  • Follow the recommendations in Canada's Food Guide and visit the BC Cancer Agency’s Prevention page on Nutrition information and resources. 
  • Visit the BC Cancer Agency’s Prevention page on Physical Activity for information and resources. 
  • Having high blood pressure is a risk factor for kidney cancer. Talk to your doctor about monitoring and managing your blood pressure.

Screening for this cancer

No effective screening program exists for this cancer yet.

If you have a family history of kidney cancer or of if a member of your family has developed kidney cancer at young age (< 45 years), you should discuss it with your doctor.

Signs and Symptoms

  • Often there are no symptoms.
  • Detection of kidney tumours at an early stage is difficult.
  • Blood in the urine (hematuria). The blood may be invisible, but can be detected by a urine test.
  • A dull persistent pain in the flank region, around the back and side of the abdomen.
  • Fullness in the upper abdomen or a distinct lump in this area.
  • In 15% - 20% of patients all three of the above symptoms are present and disappear upon removal of the tumour.
  • High blood pressure is reported in about 25% of patients and disappears upon removal of the tumour.
  • Fever might be present. Recurrent fevers might be a sign.
  • Loss of appetite, with or without nausea and vomiting.
  • Constipation, weakness and fatigue are occasionally seen.
  • Anemia or polycythemia (low or high red blood cell count).
  • Unexplained weight loss without dieting.
Diagnosis & staging


These are tests that may be used to diagnose this type of cancer.

  • Urine tests
  • Blood tests
  • X-ray examinations are used a lot
  • IVP - Intravenous Pyelogram – also known as 'excretory urogram' – this is an X-ray mapping of the kidneys and area. A dye, called a contrast medium, is injected into the bloodstream and a series of x-rays are taken. As the dye moves through the kidneys, ureters and bladder, the x-rays provide a picture of any blockages, which shows where the tumour is located.
  • Arteriogram – a dye is injected that enters the kidney through the arteries, enabling the biggest arteries to be seen. This test is rarely used today.
  • Ultrasound
  • CT scans
For more information on tests used to diagnose cancer, see our Recommended Websites, Diagnostic Tests section.

Types and Stages

  • Renal cell carcinomas (also called adenocarcinomas) are the most common (85%) of all kidney cancers.
    • The peak incidence is between age 50 - 70.
    • Men are affected twice as much as women [see note, Statistics].
  • Transitional cell carcinomas
    • These tumours occur in the renal pelvis.
    • They affect the kidney's collecting systems and behave like cancers of the bladder or ureter, so BC Cancer treats these cancer the same way we treat transitional cell carcinomas of the bladder.
    • Constitutes 8% of kidney tumours.
    • 50% of patients have invasion of underlying muscle at diagnosis.
    • Usually affects people aged 60 - 80.
  • Wilms' Tumour
    • Found mostly in children.
    • Accounts for 5% of all kidney cancers.
Staging describes the extent of a cancer. The TNM classification system is used as the standard around the world. In general a lower number in each category means a better prognosis. The stage of the cancer is used to plan the treatment.

T describes the site and size of the main tumour (primary)

N describes involvement of lymph nodes

M relates to whether the cancer has spread (presence or absence of distant metastases)

Stage I
Limited to the kidney, smaller than 7 cm across. 5-year survival approx. 90%

Stage II
Limited to the kidney, bigger than 7 cm across. 5-year survival approx. 80%

Stage III
Invasion of blood vessels near the kidney, into one lymph node near the kidney, or into the renal fat surrounding the kidney. 5-year survival approx. 50%

Stage IV
Regional lymph node involvement or metastases. 5-year survival approx. 10-20%



Cancer therapies can be highly individualized – your treatment may differ from what is described below.

  • Spontaneous remission (temporary or permanent cure without treatment) is more common in kidney cancer than in most other types of cancer, but is still very rare.
  • Children – Kidney cancers in children, including Wilms' Tumours, are treated at BC Children's Hospital.
  • Surgery is the preferred treatment for renal cell carcinomas because it offers the best chance for cure.
  • Nephrectomy is the removal of the affected kidney, possibly large portions of the surrounding tissues, and tying off the renal vein and artery. Some lymph nodes might also be taken, to see if the cancer has spread.
  • Removal of the kidney will relieve any pain or discomfort.
  • Renal pelvis tumours are usually also treated surgically and in most of these cases the kidney and the ureter are removed.
  • Interferon-alpha, a form of immune system therapy (also called immunotherapy or biological therapy) is sometimes used to treat kidney cancer that has spread (metastases).
Radiation therapy
  • Radiation therapy is not useful as a primary treatment, but may be used to relieve pain, or as palliative treatment for advanced cancer.
  • Chemotherapy is usually not effective against kidney cancer, except renal pelvis tumours (transitional cell).
  • Standard therapy for patients with tumour spread (metastases) are anti-angiogenesis inhibitors (drugs which interfere with the formation of blood vessels which could feed the tumour).

Follow-up after treatment

  • Guidelines for follow-up after treatment are covered on our website.
  • You will be returned to the care of your family doctor or specialist for regular follow-up. If you do not have a family physician, please discuss this with your BC Cancer oncologist or nurse.
  • Follow-up testing is based on your type of cancer and your particular individual circumstances.
  • Life after Cancer focuses on the issues that cancer survivors can face.
Tab Heading
SOURCE: Kidney ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2021 Provincial Health Services Authority